🚀 VC round data is live in beta, check it out!
SpectraCure Valuation Multiples
Discover revenue and EBITDA valuation multiples for SpectraCure and similar public comparables like Phase Holographic, CM International, Zenicor Medical Systems, Qlife Holding and more.
SpectraCure Overview
About SpectraCure
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Founded
2003
HQ
Employees
12
Website
Sectors
Financials (FY)
EV
$2M
SpectraCure Financials
SpectraCure reported last fiscal year revenue of — and negative EBITDA of ($3M).
In the same fiscal year, SpectraCure generated $1M in gross profit, ($3M) in EBITDA losses, and had net loss of ($6M).
SpectraCure P&L
In the most recent fiscal year, SpectraCure reported revenue of — and EBITDA of ($3M).
SpectraCure expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| EBITDA | — | XXX | ($3M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($6M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SpectraCure Stock Performance
SpectraCure has current market cap of $4M, and enterprise value of $2M.
Market Cap Evolution
SpectraCure's stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $4M | 1.0% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSpectraCure Valuation Multiples
SpectraCure trades at (0.7x) EV/EBITDA.
SpectraCure Financial Valuation Multiples
As of April 8, 2026, SpectraCure has market cap of $4M and EV of $2M.
Equity research analysts estimate SpectraCure's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SpectraCure has a P/E ratio of (0.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4M | XXX | $4M | XXX | XXX | XXX |
| EV (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.7x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (0.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.4x | XXX | XXX | XXX |
| P/E | — | XXX | (0.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SpectraCure Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SpectraCure Margins & Growth Rates
SpectraCure's revenue in the last fiscal year grew by —.
SpectraCure's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.
SpectraCure Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SpectraCure Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Phase Holographic | XXX | XXX | XXX | XXX | XXX | XXX |
| CM International | XXX | XXX | XXX | XXX | XXX | XXX |
| Zenicor Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Qlife Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Co-Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SpectraCure M&A Activity
SpectraCure acquired XXX companies to date.
Last acquisition by SpectraCure was on XXXXXXXX, XXXXX. SpectraCure acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SpectraCure
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSpectraCure Investment Activity
SpectraCure invested in XXX companies to date.
SpectraCure made its latest investment on XXXXXXXX, XXXXX. SpectraCure invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SpectraCure
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SpectraCure
| When was SpectraCure founded? | SpectraCure was founded in 2003. |
| Where is SpectraCure headquartered? | SpectraCure is headquartered in Sweden. |
| How many employees does SpectraCure have? | As of today, SpectraCure has over 12 employees. |
| Is SpectraCure publicly listed? | Yes, SpectraCure is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of SpectraCure? | SpectraCure trades under SPEC ticker. |
| When did SpectraCure go public? | SpectraCure went public in 2015. |
| Who are competitors of SpectraCure? | SpectraCure main competitors are Phase Holographic, CM International, Zenicor Medical Systems, Qlife Holding. |
| What is the current market cap of SpectraCure? | SpectraCure's current market cap is $4M. |
| Is SpectraCure profitable? | No, SpectraCure is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.